Twist Bioscience Corp (TWST)
41.70
+0.13
(+0.31%)
USD |
NASDAQ |
Nov 04, 12:57
Twist Bioscience Shareholders Equity (Quarterly): 491.14M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 491.14M |
March 31, 2024 | 560.13M |
December 31, 2023 | 590.04M |
September 30, 2023 | 623.43M |
June 30, 2023 | 657.55M |
March 31, 2023 | 703.93M |
December 31, 2022 | 746.32M |
September 30, 2022 | 789.38M |
June 30, 2022 | 820.68M |
March 31, 2022 | 863.36M |
December 31, 2021 | 626.18M |
September 30, 2021 | 580.82M |
June 30, 2021 | 610.45M |
Date | Value |
---|---|
March 31, 2021 | 614.18M |
December 31, 2020 | 637.95M |
September 30, 2020 | 336.26M |
June 30, 2020 | 348.95M |
March 31, 2020 | 264.20M |
December 31, 2019 | 103.08M |
September 30, 2019 | 152.08M |
June 30, 2019 | 176.00M |
March 31, 2019 | 115.48M |
December 31, 2018 | 138.60M |
September 30, 2018 | -201.42M |
June 30, 2018 | 96.46M |
September 30, 2017 | -133.36M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
103.08M
Minimum
Dec 2019
863.36M
Maximum
Mar 2022
577.27M
Average
614.18M
Median
Mar 2021
Shareholders Equity (Quarterly) Benchmarks
ResMed Inc | 5.195B |
RxSight Inc | 275.21M |
Perspective Therapeutics Inc | 341.00M |
Xtant Medical Holdings Inc | 45.00M |
Catheter Precision Inc | 14.32M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 638.12M |
Total Liabilities (Quarterly) | 146.98M |
Current Ratio | 4.906 |